Shigematsu Works Co., Ltd.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Shigematsu Works Co., Ltd.'s yearly results (2023–2026), compared with Healthcare companies in Japan. Tap ? on any ratio for what it means.
What stands out
- Cash Cushion Ratio: Debt, after subtracting cash, equals 87% of its market value (net debt). Lower than 89% of Healthcare companies in Japan.
Where ¥100 of sales goes
Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
¥117Over the last 3 years, every ¥100 of reported profit came with ¥117 of operating cash.
Lower than 59% of Healthcare companies in Japan.
Self-Funding Ratio
0.4×Over the last 3 years its own operating cash paid for 42% of its investment spending (capex); the rest came from other sources such as borrowing, cash reserves or new shares.
Lower than 71% of Healthcare companies in Japan.
Cash Locked Ratio
¥40For every ¥100 of sales, ¥40 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against ¥41 tied up three years earlier.
More money tied up than 79% of Healthcare companies in Japan.
Growth quality
Steadiness Ratio
3/3 · 1/3Sales grew in 3 of the last 3 years; profit grew in 1 of 3.
Less steady than 55% of Healthcare companies in Japan.
Growth Efficiency Ratio
−¥2Sales grew 21% in 3 years, but profit fell: ¥2 less profit per ¥100 of extra sales.
Lower than 73% of Healthcare companies in Japan.
Asset Productivity Ratio
+21% / +42%In 3 years sales changed by +21% while total assets changed by +42%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
0.4×Debt due within a year is covered 0.4 times by its yearly operating cash.
Lower than 59% of Healthcare companies in Japan.
Cash Cushion Ratio
−87%Debt, after subtracting cash, equals 87% of its market value (net debt).
Lower than 89% of Healthcare companies in Japan.
Tangible Assets Ratio
98%Of every ¥100 the company owns, ¥98 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 54% of Healthcare companies in Japan.
Tangible Net Worth Ratio
95%Of every ¥100 of net worth, ¥95 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 53% of Healthcare companies in Japan.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
Shigematsu Works Co., Ltd. owes ¥0.56 for every ¥1 it owns. Net profit fell 10% in the year to Mar 2026, and shrank 2% a year on average over 3 years.
Compared with Healthcare companies in Japan · latest annual results Mar 2026.
P/E ratio
7.6Investors pay ¥7.6 for every ¥1 of Shigematsu Works Co., Ltd.'s yearly profit, lower than 96% of Healthcare companies in Japan.
P/B ratio
0.63The share price is 0.63 times Shigematsu Works Co., Ltd.'s book value per share, lower than 94% of Healthcare companies in Japan.
Market cap
¥6.0 BThe total market value of all of Shigematsu Works Co., Ltd.'s shares at today's price (share price × number of shares), smaller than 74% of Healthcare companies in Japan. PosiCap size class: Micro Cap.
Net worth (book value)
¥9.4 BWhat Shigematsu Works Co., Ltd. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
¥1,327Net worth divided by the number of shares. The share price of ¥838.00 is 0.6 times this, which is the P/B above.
Return on equity (ROE)
8.6%Shigematsu Works Co., Ltd. earned 8.6% on its shareholders' money over the last year, higher than 57% of Healthcare companies in Japan.
Owes vs Owns
0.56×Shigematsu Works Co., Ltd. owes ¥0.56 for every ¥1 it owns (moderate), higher than 69% of Healthcare companies in Japan.
Dividend yield
1.78%Shigematsu Works Co., Ltd. pays 1.78% of its share price as dividends a year, lower than 76% of dividend-paying Healthcare companies in Japan.
Revenue growth
+10%Revenue rose 10% in the year to Mar 2026, and grew 7% a year on average over 3 years.
Profit growth
-10%Net profit fell 10% in the year to Mar 2026, and shrank 2% a year on average over 3 years.
Profit margin
4.5%Shigematsu Works Co., Ltd. keeps ¥5 of every ¥100 of revenue as net profit.
Cash quality
1.7×Cash from Shigematsu Works Co., Ltd.'s business was 1.7× its reported profit in the year to Mar 2026 — its profit turned into cash.
Interest cover
12.7×Shigematsu Works Co., Ltd.'s operating profit covered its interest costs 12.7 times in the year to Mar 2026.
Cash vs debt
Net debtShigematsu Works Co., Ltd. had ¥5.2 B more debt than cash (net debt) at Mar 2026.
Questions
What is Shigematsu Works Co., Ltd.'s P/E ratio?
Investors pay ¥7.6 for every ¥1 of Shigematsu Works Co., Ltd.'s yearly profit, lower than 96% of Healthcare companies in Japan.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Shigematsu Works Co., Ltd.: ¥6.0 B ÷ ¥9.4 B (31 Mar 2026) = 0.6.
What is Shigematsu Works Co., Ltd.'s return on equity?
Shigematsu Works Co., Ltd. earned 8.6% on its shareholders' money over the last year, higher than 57% of Healthcare companies in Japan.
How much does Shigematsu Works Co., Ltd. owe compared with what it owns?
Shigematsu Works Co., Ltd. owes ¥0.56 for every ¥1 it owns (moderate), higher than 69% of Healthcare companies in Japan.
Does Shigematsu Works Co., Ltd. pay a dividend?
Yes. Shigematsu Works Co., Ltd. pays 1.78% of its share price as dividends a year, lower than 76% of dividend-paying Healthcare companies in Japan.
Is Shigematsu Works Co., Ltd.'s revenue growing?
Revenue rose 10% in the year to Mar 2026, and grew 7% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.